spacer
home > ebr > spring 2003 > omega-3 fatty acids in the prevention of myocardial infarction
PUBLICATIONS
European Biopharmaceutical Review

Omega-3 Fatty Acids in the Prevention of Myocardial Infarction

Atherosclerosis is an arterial disease causing myocardial infarction and stroke, angina pectoris and sudden death. Atherosclerosis is responsible for about 60 per cent of total mortality in the US and about 22 per cent of the population has one or more types of cardiovascular disease (1). Atherosclerosis is therefore the main threat to life and health in industrialised society today.

Sclerosis means hardening, but this pathological feature is common and in general accepted as a rather benign disease: a normal ageing of the artery. Pathologists recognise two different types of atherosclerotic plaques: large, firm plaques consisting of organised connective tissue and small, soft plaques containing lipids and inflammatory cells. The large sclerotic plaques are stable, hard structures not likely to disrupt normal function, but nevertheless show up clearly on the angiogram.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Morten Bryhn, Director of R&D at Pronova Biocare

Dr Morten Bryhn is a specialist in cardiology and internal medicine, holding a PhD and an Assistant Professorship in the field of cardiology.

Dr Bryhn currently serves as Director of R&D at Pronova Biocare and has published around 100 scientific articles, several of which deal with the effects of omega-3 fatty acids.
 

spacer
Dr Morten Bryhn
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

6th European Forum for Qualified Person for Pharmacovigilance (QPPV)

24-26 April 2012, London, UK

This event is for European qualified persons for pharmacovigilance; deputy qualified persons; senior pharmacovigilance regulators and inspectors; CROs and consultants providing QPPV services; and national responsible persons for pharmacovigilance.
More info >>

 
News and Press Releases

Pantec Biosolutions Showcases P.L.E.A.S.E.® Professional at the IMCAS Annual Congress

Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will present its recently launched P.L.E.A.S.E.® Professional laser device at the International Master Course on Aging Skin (IMCAS) from 26th-29th January 2012 in Paris, France.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.